---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-051575"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:57:46.034307+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Onconetix shareholders approve reverse stock split up to 1-for-10

## Summary
- Reverse split proposal approved with 1,301,918 for, 253,378 against, 1,393 abstentions.
- Board may implement one or more splits at ratios between 1:2 and 1:10 within one year, not exceeding 1:100 aggregate.
- Adjournment proposal also approved with 1,332,088 for, 223,071 against, 1,530 abstentions.
- Reverse split authorized without further stockholder approval; exact ratio to be set by the board.

## SEC filing metadata
- accession: 0001213900-26-051575
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/0001213900-26-051575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/ea0288982-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-051575
- JSON: https://secwatch.observer/filing/0001213900-26-051575.json
- Plain text: https://secwatch.observer/filing/0001213900-26-051575.txt

## Key facts
- Shareholder Votes
  Onconetix, Inc. shareholders approved Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of all of the outstanding shares of the Company's common stock, par value $0.00001 per share, at a ratio in the range of 1-for-2 to 1-for-10, at any time prior to th at the 2026-04-30 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2026-04-30
  source text: 1. Reverse Stock Split Proposal The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,301,918 253,378 1,393
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/0001213900-26-051575-index.htm
- Shareholder Votes
  Onconetix, Inc. shareholders approved Approval of the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal. at the 2026-04-30 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2026-04-30
  source text: 2. The Adjournment Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,332,088 223,071 1,530
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390026051575/0001213900-26-051575-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.